Penn Medicine Provider
Gastroenterology
Faten N. Aberra, MD, MSCE
4.9
(243)
Sees patients age 18 and up
Penn Gastroenterology Perelman
View 1 additional location

About me

  • Interim Director, Inflammatory Bowel Disease Center
  • Associate Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Dartmouth Medical School
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

246 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
friendly and caring
April 2025
5.0
5.0
dr. aberra been my physician for 15 yrs she knows what she doing and i trust her with my health.
April 2025
5.0
5.0
she is knowledgeable, intelligent, good bedside manner.
April 2025
5.0
5.0
knowledge and patient relations are amazing

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Aberra is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Blonski W, kundu R, Lewis J, Aberra F, Osterman M, and Lichtenstein GR. Is dysplasia visible during surveillance colonoscopy in ulcerative colitis? , Scandinavian Journal of Gastroenterology, 43(6): 2008,698-703


Blonski W, Kundu R, Furth EF, Lewis J, Aberra F, and Lichtenstein GR High-Grade Dysplastic Adenoma-Like Mass Lesions are not an Indication for Colectomy in Patients with Ulcerative Colitis , Scandinavian Journal of Gastroenterology, 43(7): 2008,817-820


James D. Lewis, Shaokun Chuai, Lisa Nessel, Gary R. Lichtenstein, Faten N. Aberra, Jonas H. Ellenberg Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis , Inflammatory Bowel Diseases, 14(12): 2008,1660-1666


Aberra, F.A., Stettler, N, Brensinger C, Lichtenstein G.R., Lewis, J.D Risk for Active Tuberculosis in Inflammatory Bowel Disease Patients , Clinical Gastroenterology and Hepatology, 5(9): 2007,1070-5


Aberra FN, Lichtenstein GR Infliximab in Ulcerative Colitis , Gastroenterology Clinics of North America, 35(4): 2006,821-836


Aberra, F To be or not to be with infliximab during pregnancy? , Inflammatory Bowel Diseases, 12(1): 2006,76-78


Aberra, F.A., Brensinger, C. M., Bilker, W.B., Lichtenstein, G.R., Lewis, J.D Antibiotic Use and the Risk of Flare of Inflammatory Bowel Disease , Clinical Gastroenterology and Hepatology, 3(5): 2005,459-465


Aberra, F.A., Lewis, J.D., Haas, D, Rombeau J.L., Osborne, B, Lichtenstein, G.R Preoperative Use of Azathioprine, 6-Mercaptopurine, or Corticosteroids and Risk for Postoperative Infectious Complications in Inflammatory Bowel Disease Patients Having Elective Bowel Surgery , Gastroenterology, 125(2): 2003,320-327


View all publications